Bosutinib

Drugbox
IUPAC_name = 4- [(2,4-dichloro-5-methoxyphenyl)amino] -6-methoxy-7- [3-(4-methylpiperazin-1-yl)propoxy] quinoline-3-carbonitrile

---

CAS_number = 380843-75-4
CAS_supplemental =
ATC_prefix =
ATC_suffix =
ATC_supplemental =
PubChem = 5328940
DrugBank =
chemical_formula =
C=26 | H=29 | Cl=2 | N=5 | O=3
molecular_weight = 530.446 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =

Bosutinib (rINN/USAN; codenamed SKI-606) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer.

It is being developed by Wyeth.

Links

http://www.eurekalert.org/pub_releases/2007-12/uotm-epi120707.phphttp://professional.cancerconsultants.com/oncology_main_news.aspx?id=39941